UREMIDE

This brand name is authorized in Australia, South Africa

Active ingredients

The drug UREMIDE contains one active pharmaceutical ingredient (API):

1 Furosemide UNII 7LXU5N7ZO5 - FUROSEMIDE

Furosemide inhibits active chloride transport in the thick ascending limb. Re-absorption of sodium, chloride from the nephron is reduced and a hypotonic or isotonic urine produced. The evidence from many experimental studies suggests that furosemide acts along the entire nephron with the exception of the distal exchange site. Read about Furosemide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
UREMIDE Tablet	Marketing Authorisation Holder	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C03CA01	Furosemide	C Cardiovascular system → C03 Diuretics → C03C High-ceiling diuretics → C03CA Sulfonamides, plain
Discover more medicines within C03CA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 2412Y
Country: ZA	Health Products Regulatory Authority	Identifier(s): J/18.1/357